BIOTRONIK releases line-extension of Orsiro Hybrid Drug Eluting Stent
The highly deliverable Orsiro stent is now available in lengths up to 40 mm to address a wider range of lesionsBERLIN, Germany, September 2, 2013—BIOTRONIK , a leading manufacturer of innovative medical technology, has announced the market release of new 35 and 40 mm versions of Orsiro, the industry’s first hybridDES (Drug Eluting Stent) featuring a bioabsorbable polymer. BIOTRONIK now offers one of the longest drug-eluting stents on the market across all diameters. The Orsiro 40 mm was first implanted by Dr. Heinz-